SaiamaNaheedWaqarMD

Oncology • Saint Louis, MO

Thoracic Cancer

Associate Professor, Division of Oncology, Washington University School of Medicine

Join to view full profile

Dr. Waqar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Waqar's full profile

Already have an account?

Office
660 S Euclid Ave
Campus Box 8056
Saint Louis, MO 63110
Phone+1 314-747-7409

Fax+1 314-362-3895
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2008 - 2011
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2005 - 2008
Aga Khan Medical CollegeClass of 2001

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 2008 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC Start of enrollment: 2010 Dec 01
Completed
Phase 1, Phase 2
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
Terminated
Phase 2, Phase 3
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite Start of enrollment: 2013 Sep 01
Withdrawn
Phase 2
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer Start of enrollment: 2012 Jun 01
Completed
Phase 1, Phase 2
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer Start of enrollment: 2012 Jun 01
Completed
Phase 2
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies Start of enrollment: 2013 May 07
Completed
Phase 1
Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy Start of enrollment: 2011 Sep 01
Terminated
Phase 1
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors Start of enrollment: 2013 May 03
Terminated
Phase 1, Phase 2
Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer Start of enrollment: 2014 May 22
Completed
Phase 1
Pazopanib in Molecularly Selected Patients With Advanced NSCLC Start of enrollment: 2015 Apr 27
Terminated
Phase 2
Falls Risk Questionnaire in Older Adults With Cancer Start of enrollment: 2014 Aug 01
Completed
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors Start of enrollment: 2015 Jun 01
Active, not recruiting
Phase 1
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors Start of enrollment: 2015 Dec 01
Withdrawn
Phase 1
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Start of enrollment: 2015 Nov 19
Active, not recruiting
Phase 2
Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2016 May 01
Withdrawn
Phase 2
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors Start of enrollment: 2016 Sep 23
Terminated
Phase 1, Phase 2
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Start of enrollment: 2016 May 11
Completed
Phase 2
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients Start of enrollment: 2016 Jun 01
Active, not recruiting
Phase 3
Optimizing Fall-risk Prediction in Older Adults With Cancer Start of enrollment: 2016 Oct 12
Completed
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC Start of enrollment: 2017 Jun 29
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

The changing landscape of small cell lung cancer.
Giordano Fabricio Cittolin-Santos, Bharath Ganesh, Feng Gao, Saiama Waqar, Thomas Eldridge Stinchcombe, Ramaswamy Govindan, Daniel Morgensztern, Knapp, B., Brendan Knapp> ;Cancer. 2024 Mar 12
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Owen, D. H., Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard...> ;Nature Medicine. 2024 Jan 1
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.
Nicholas P Semenkovich, Shahed N Badiyan, Pamela P Samson, Hayley B Stowe, Yun E Wang, Rachel Star, Siddhartha Devarakonda, Ramaswamy Govindan, Saiama N Waqar, Cliffor...> ;NPJ Precision Oncology. 2023 Oct 2
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).
Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst, David R Gandara, Joel W Neal, Ticiana A Leal, Jyoti D Patel, Konstantin H Dragnev, Saiama N ...> ;JCO Precision Oncology. 2023 Sep 1
1 citations
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.
Nicholas P Semenkovich, Pamela P Samson, Shahed N Badiyan, Gregory Vlacich, Hayley B Stowe, Yun E Wang, Rachel Star, Siddhartha Devarakonda, Ramaswamy Govindan, Saiama...> ;Research Square. 2023 Mar 22
1 citations
Trajectories of participation in daily life among individuals newly diagnosed with cancer: A 5-month longitudinal study.
Allison J L'Hotta, Yan Yan, Andrew A Davis, Saiama N Waqar, Milan G Chheda, Benjamin R Tan, Kathleen D Lyons, Yikyung Park, Allison A King> ;Supportive Care in Cancer. 2023 Mar 14
12 citations
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
Jeffrey Bogart, Xiaofei Wang, Gregory Masters, Junheng Gao, Ritsuko Komaki, Laurie E Gaspar, John Heymach, James Bonner, Charles Kuzma, Saiama Waqar, William Petty, Th...> ;Journal of Clinical Oncology. 2023 May 1
3 citations
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced gliob...
Benedito A Carneiro, Kyriakos P Papadopoulos, John H Strickler, Andrew B Lassman, Saiama N Waqar, Young Kwang Chae, Jyoti D Patel, Einat Shacham-Shmueli, Karen Kelly, ...> ;Neuro-Oncology Advances. 2022 Dec 21
6 citations
Trends in Stage I Lung Cancer.
Aashray Singareddy, Mary Ellen Flanagan, Pamela P Samson, Saiama N Waqar, Siddhartha Devarakonda, Jeffrey P Ward, Brett H Herzog, Anjali Rohatgi, Clifford G Robinson, ...> ;Clinical Lung Cancer. 2023 Mar 1
5 citations
Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors.
Brett H Herzog, Saiama N Waqar, Siddhartha Devarakonda, Jeffrey P Ward, Feng Gao, Ramaswamy Govindan, Daniel Morgensztern> ;Lung Cancer. 2022 Nov 1
81 citations
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard Lozanski, Ma...> ;Nature Medicine. 2022 Oct 1
5 citations
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer.
Jessika Contreras, Amar Srivastava, Pamela Samson, Todd DeWees, Ramaswamy Govindan, Maria Q Baggstrom, Daniel Morgensztern, Michael Roach, Shahed N Badiyan, Jeffrey Br...> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Jul 15
1 citations
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience.
Neha Mehta-Shah, Nancy L Bartlett, Brad Kahl, Marcus P Watkins, Amalia Dubois, Gabby Schmelzle, Saiama Waqar, Claire Ballman, Fei Wan, Christopher W Farnsworth> ;Leukemia & Lymphoma. 2022 Jul 1
15 citations
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors.
Saiama N Waqar, Clifford Robinson, Anthony J Olszanski, Alexander Spira, Melissa Hackmaster, Luisa Lucas, Laura Sponton, Hulin Jin, Ursula Hering, Damien Cronier, Mari...> ;Investigational New Drugs. 2022 Jun 1
1 citations
Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors.
Saiama N Waqar, Clifford Robinson, Anthony J Olszanski, Alexander Spira, Melissa Hackmaster, Luisa Lucas, Laura Sponton, Hulin Jin, Ursula Hering, Damien Cronier, Mari...> ;Investigational New Drugs. 2022 Jun 1
4 citations
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors.
Nusayba A Bagegni, Haeseong Park, Katlyn Kraft, Maura O-Toole, Feng Gao, Saiama N Waqar, Lee Ratner, Daniel Morgensztern, Siddhartha Devarakonda, Manik Amin, Maria Q B...> ;Cancer Chemotherapy and Pharmacology. 2022 Apr 1
29 citations
Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer.
Jeffrey A Bogart, Saiama N Waqar, Michael D Mix> ;Journal of Clinical Oncology. 2022 Feb 20
2 citations
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer.
Brendan Knapp, Laura Mezquita, Siddhartha Devarakonda, Mihaela Aldea, Saiama N Waqar, Kym Pepin, Jeffrey P Ward, Angela Botticella, Karen Howarth, Charlene Knape, Cliv...> ;Frontiers in Oncology. 2022 Jan 1
119 citations
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, Collin Blakely, Anne Chiang, Thomas A D'Amico, Christopher D'Avella, Afshin Dowlati, Robert J Downey, Martin Edelma...> ;Journal of the National Comprehensive Cancer Network. 2021 Dec 1
32 citations
Genomic Profiling of Lung Adenocarcinoma in Never-Smokers
Siddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, Sumithra Sankararaman, Humam Kadara, Chandra Goparaju, Irena Lanc, Kymberlie H. Pepin, Saiama N. Waqar, Da...> ;Journal of Clinical Oncology. 2021 Sep 30
22 citations
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors.
Aaron S. Mansfield, David S. Hong, Christine L. Hann, Anna F. Farago, Himisha Beltran, Saiama N. Waqar, Andrew Eugene Hendifar, Lowell B. Anthony, Matthew H. Taylor, A...> ;NPJ Precision Oncology. 2021 Aug 5
5 citations
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies.
Kian-Huat Lim, Mateusz Opyrchal, Abhi Acharya, Nick Boice, Ningying Wu, Feng Gao, Jace Webster, Albert C. Lockhart, Saiama N. Waqar, Ramaswamy Govindan, Daniel Morgens...> ;European Journal of Cancer. 2021 Jul 10
7 citations
A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations
Siddhartha Devarakonda, Bruna Pellini, Luke Verghese, Haeseong Park, Daniel Morgensztern, Ramaswamy Govindan, Rama Suresh, Peter Oppelt, Maria Q. Baggstrom, Ningying W...> ;Journal of Thoracic Disease. 2021 Jul 1
21 citations
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial.
Alice P. Chen, S. Kummar, Nancy Moore, Larry Rubinstein, Yingdong Zhao, P. Mickey Williams, Alida Palmisano, David J. Sims, Geraldine O'Sullivan Coyne, Christina L. Ro...> ;JCO Precision Oncology. 2021 Jan 12
2 citations
Adjuvant Therapy With EGFR Tyrosine Kinase Inhibitors: Tempering Great Expectations With Realism.
Saiama N. Waqar, Ramaswamy Govindan> ;Journal of Clinical Oncology. 2021 Jan 8
Join now to see all

Journal Articles

Recurrent WNT Pathway Alterations Are Frequent in Relapsed Small Cell Lung Cancer
Saiama N. Waqar, Daniel Morgensztern, Robert S. Fulton, Ramaswamy Govindan, Nature

Lectures